Today: 20 May 2026
Spotify stock falls after Premium price hike to $12.99 — what SPOT investors watch next
16 January 2026
2 mins read

Spotify stock falls after Premium price hike to $12.99 — what SPOT investors watch next

New York, Jan 15, 2026, 17:40 ET — Trading in the after-hours session.

  • Spotify announced it will raise the U.S. Premium plan price by $1, moving it to $12.99 a month beginning in February.
  • SPOT fell roughly 4% after hours, lagging behind the broader U.S. market rally.
  • Investors are focused on subscriber churn and eagerly awaiting the next earnings report due Feb. 10.

Spotify Technology S.A. (SPOT) slid 3.9% to $508.04 in after-hours Thursday following the announcement that its monthly Premium plan price will jump $1 to $12.99 in the U.S. The hike also affects Estonia and Latvia, kicking in on users’ billing dates starting February.

Spotify’s growth hinges on just two paths now: boosting paying users or squeezing more value from each one. That $1 uptick is a straightforward test of its pricing power, with no fresh product launch to distract.

Investors are keeping an eye on churn — that’s the jargon for customers who drop out — since hiking prices can quickly backfire when competitors are just a tap away. Spotify has been pushing price increases more aggressively, prompting questions about how much room they have left to raise rates.

Spotify announced that Premium subscribers in the impacted regions will receive emails over the coming month detailing the update. The company described the adjustment as an “occasional” revision aimed at better reflecting the service’s value and backing both the listening experience and the artists. Spotify

U.S. subscribers are facing their third Spotify Premium price hike since 2023, following the previous increase in June 2024. The company is also raising rates for its Student, Duo, and Family plans across the country, reports.

Spotify reports 281 million subscribers and 713 million monthly active users worldwide, with its U.S. Premium segment still driving a disproportionate share of revenue amid expansion into podcasts and audiobooks. The platform now boasts over 100 million tracks, close to 7 million podcast titles, and 350,000 audiobooks available individually.

The stock has taken a hit, dropping roughly a third since its late-June peak near $776. Analysts have lowered their price targets after Spotify signaled a slowdown, projecting just 6% revenue growth for the fourth quarter when it reported earnings in November.

Oppenheimer analyst Jason Helfstein said Tuesday that price hikes might help steer the shares “back on track.” The firm lowered its price target to $750 from $825 but maintained an Outperform rating. Barron’s

Spotify’s shares fell even as the wider U.S. market steadied, boosted by gains in chipmakers and big banks following strong earnings from Taiwan Semiconductor Manufacturing and U.S. financial firms.

The risk is clear: as prices climb, some users will shift to cheaper plans or switch to competitors like Apple Music and Amazon Music. Cancelations are likely to rise as households face growing streaming costs. The Labor Department’s inflation measure, which factors in subscription video services, jumped 19.5% in December, Axios reported.

On Feb. 10, Spotify is set to unveil its earnings before markets open. Investors will focus on any initial signs of cancellations following the price-change notifications, along with whether ad demand is showing growth or merely stabilizing.

Stock Market Today

  • Tesla Q1 2026 Earnings Beat; Stock Faces Mixed Outlook for 2030
    May 20, 2026, 10:24 AM EDT. Tesla (TSLA) reported Q1 2026 earnings per share (EPS) of $0.41, exceeding the $0.36 consensus, with automotive gross margin rising to 21.1% from 16.2%. Operating income increased 135.8% year-on-year (YoY), and services plus Full Self-Driving (FSD) revenue jumped 42% to $3.75 billion, with 1.28 million active FSD subscriptions up 51%. Despite strong fundamentals, Tesla shares fell 8.83% year-to-date to $409.99 amid skepticism about AI monetization and scaling autonomy. Wall Street's average target is about $412, while a proprietary model estimates a base case price of $510 by 2030, with a bull case of $645. Achieving $650 requires significant price-to-earnings multiple expansion or sharp EPS growth from AI ventures, amid challenges like increased operating expenses and production constraints.

Latest articles

POET Technologies Jumps After $400M AI Photonics Raise, Dilution Questions Linger

POET Technologies Jumps After $400M AI Photonics Raise, Dilution Questions Linger

20 May 2026
POET Technologies shares rose 11% to $14.55 in early Nasdaq trading Wednesday after closing a US$400 million direct offering of 19 million shares and warrants. The rebound followed an 8% drop Tuesday on dilution concerns. The company reported Q1 revenue of $503,389 and a net loss of $12.3 million. A recent $50 million order from Lumilens could scale to $500 million over five years if production ramps up.
Nokia’s U.S. Broadband Order Arrives While AI-Driven Gains Test Supply Chain

Nokia’s U.S. Broadband Order Arrives While AI-Driven Gains Test Supply Chain

20 May 2026
Nokia shares rose 3.37% in Helsinki trading Wednesday after the FCC conditionally approved its Beacons and ONT devices, exempting them from U.S. Covered List restrictions. Nokia also transferred 975,289 treasury shares to equity plan participants. Dell’Oro Group forecasts the optical transport equipment market will grow 16% in 2026, driven by AI data centers.
Apellis Shares Disappear After Biogen’s $5.6 Billion Buy—One Play Left

Apellis Shares Disappear After Biogen’s $5.6 Billion Buy—One Play Left

20 May 2026
Biogen completed its acquisition of Apellis Pharmaceuticals, removing APLS shares from Nasdaq and paying investors $41 per share plus a contingent value right tied to Syfovre sales. Apellis shareholders tendered 82.4% of outstanding stock before the offer expired May 13. Biogen shares rose 0.9% to $192.34 Wednesday. The CVR could pay up to $4 if Syfovre meets future sales targets.
Salesforce stock drops after-hours as AI-agent scare hangs over new Davos, Google moves
Previous Story

Salesforce stock drops after-hours as AI-agent scare hangs over new Davos, Google moves

Boston Scientific (BSX) stock drops after $14.5B Penumbra deal; FDA nod and earnings date ahead
Next Story

Boston Scientific (BSX) stock drops after $14.5B Penumbra deal; FDA nod and earnings date ahead

Go toTop